Albany, NY -- (SBWIRE) -- 05/26/2016 -- Transparency Market Research has published a new market report titled, "Hospital Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023." According to the report, the global hospital pharmaceuticals market was valued at US$ 197.3 Bn in 2014 and is anticipated to expand at a CAGR of 3.9% from 2015 to 2023 to reach US$ 280.3 Bn by 2023.

Hospital pharmaceuticals are medications administered to both inpatients and outpatients in hospital settings. The hospital pharmaceuticals market has been segmented based on type of indication for therapeutic areas such as cardiology, oncology, nephrology and urology, neurology, pain, and infection. These segments are further analyzed into different categories on the basis of highly prevalent disease conditions. The market has also been analyzed based on drug class and major geographic regions. Increasing prevalence of chronic diseases, rising patient awareness, rapidly growing geriatric population, and increasing affordability of patients toward medical treatments are the major drivers of the hospital pharmaceuticals market.

High prevalence of chronic diseases has been identified as one of the major factors driving the global hospital pharmaceuticals market. In terms of indication, the oncology segment accounted for the largest share of 35.3% of the hospital pharmaceuticals market in 2014. The segment is expected to expand at a CAGR of 6.5% from 2015 to 2023. According to the World Cancer Research Fund Association, around 14.1 million cancer cases were reported globally in 2012, and this number is expected to increase to 24 million by 2035. These cases include the most common types of cancer such as lung cancer, breast cancer, prostate cancer, and colorectal cancers. Thus, large number of cancer cases require substantial quantity of hospital pharmaceuticals. Pfizer, Novartis, AstraZeneca, Roche, Sanofi, Johnson & Johnson, and Bayer are the key players in the hospital pharmaceuticals market, specifically in the oncology segment.

According to the World Health Organization, four out of five CVD deaths are due to heart attacks and strokes. Cardiovascular diseases (CVDs) account for as high as 31.0% of the total deaths worldwide. However, due to approaching saturation in the market, the estimated CAGR for the cardiology segment is indicated to be lower than other indications. According to the report, the market for nephrology and urology indications system is also expected to expand at a CAGR of 4.3%. Some of the major nephrology and urology disease indications include acute kidney failure, chronic kidney disease, glomerular diseases, diabetes, urinary tract infections and kidney stones. According to the National Kidney Foundation, U.S., around 10.0% of the world population is affected by chronic kidney disease (CKD), and millions die each year due to lack of affordable treatment.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3535

Neurological disorders are the diseases of central or peripheral nervous system. Epilepsy, Stroke, Parkinson's disease, multiple sclerosis, Alzheimer's disease are some of the major neurological indications affecting millions of people worldwide. The World Heart Federation suggests that every year, 15 million people worldwide suffer a stroke, whereas nearly six million die and five million are left permanently disabled. As per these statistics, it is suggested that stroke is the second leading cause of disability, after dementia. The report provides a detailed analysis of the global neurological diseases indications and their market. According to the American Academy of Pain Medicine, around 1.5 billion individuals around the world were suffering from one or the other kind of chronic pain in 2015. The report provides a substantial analysis on conditions like neuropathic pain, fibromyalgia, osteoarthritis, rheumatoid arthritis, cancer pain. Moreover, prominently occurring pain indications such as gout, sciatica and back pain have also been covered in the analysis for pain segment. The infection segment of the hospital pharmaceutical drugs market has also been analyzed for indications such as tuberculosis, pneumonia, hepatitis A, hepatitis B, candida infection, fungal meningitis, shigellosis, and amoebiasis.

Key players in the global hospital pharmaceuticals market are AstraZeneca plc, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Sanofi.

The global hospital pharmaceuticals market has been segmented as follows:

Global Hospital Pharmaceuticals Market, by Therapeutic Class

Cardiology
Anti-hypertensives
Dyslipidemia drugs
Others
Oncology
Alkylating Agents
Anti-metabolites
Hormonal Agents
Immunomodulating Agents
Miscellaneous Drugs
Nephrology and Urology
Diuretic Agents
Anti-hypertensive Agents
Phosphate Binders
Anticholinergic Drugs
5-Alpha Reductase Inhibitors
Neurology
Anti-anxiety Agents
Anti-migraine Drugs
Antidepressant Drugs
Anti-psychotic Drugs
Pain
Anticonvulsant Drugs
Anesthetic Drugs
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Opioids
Non-narcotics Analgesic Drugs
Infection
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Antiparasite Drugs

Global Hospital Pharmaceuticals Market, by Indication

Cardiology
Coronary Heart Diseases
Stroke
High Blood Pressure
Heart Failure
Others
Oncology
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Others
Nephrology and Urology
Acute Kidney Failure
Chronic Kidney Diseases
Glomerular Diseases
Diabetes
Others
Neurology
Epilepsy
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Others
Pain
Neuropathic Pain
Fibromyalgia
Osteoarthritis
Rheumatoid Arthritis
Cancer Pain
Infection
Tuberculosis
Pneumonia
Hepatitis A
Hepatitis B
Candida Infection
Fungal Meningitis
Shigellosis
Amoebiasis
Other

Global Hospital Pharmaceuticals Market, by Geography

North America
U.S.
Canada
Asia Pacific
China
Japan
Rest of APAC
Europe
U.K.
Germany
Rest of Europe
Latin America
Brazil
Mexico
Rest of Latin America
Rest of the World

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/